ArticleCritical care (London, England)2025
Reduced plasma levels of Copine 5 correlate with sepsis-induced vascular leakage and mortality in human patients and a murine sepsis model.
Article in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The role and mechanism of TNFRSF21 in promoting necroptosis of vascular endothelial cells and inducing vascular leakage in sepsis.Journal of molecular medicine (Berlin, Germany) · 2026Article
- Identification of MTURN as a trained immunity-related biomarker for heart failureFrontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundVascular leakage is a major cause of multiple organ failure and mortality in sepsis, and factors that regulate endothelial integrity could serve as promising biomarkers of septic shock development. Copine family members (CPNEs) are well-characterized as soluble membrane-binding proteins, whether CPNEs play a critical role in maintaining vascular integrity during sepsis, however, remains unclear.
methodsHuman aorta single-nucleus RNA-sequencing data were analyzed for the expression profile of all Copine family members (CPNE1-9). Plasma levels of CPNE5, Ang-II, sICAM-1, and SDC-1 were measured in human sepsis patients at admission and healthy donors as well as in septic mice induced by injection i.p. with cecal slurry. The correlation of CPNE5 levels to other three factors (Ang-II, sICAM-1, SDC-1) were analyzed. CPNE5-knockdown endothelial cells (ECs) and global CPNE5-knockout (KO) mice were utilized to determine the critical role of CPNE5 in sepsis-triggered vascular leakage, organ damage and mortality.
resultsAmong nine CPNEs, only CPNE5 is predominantly expressed in human aorta endothelial cells. In sepsis patients (n = 77), plasma levels of CPNE5 were significantly reduced, whereas plasma levels of Ang-II, sICAM-1, and SDC-1 were markedly elevated, compared to healthy donors (n = 44; p < 0.01). Similar findings were also observed in a murine sepsis model induced by cecal slurry (CS)-injection intraperitoneally. Furthermore, in the supernatants of cultured ECs treated with LPS or pro-inflammatory cytokine mixture (Cytomix: TNFα/IL-1β/IFNγ, each 10 ng/mL), the concentrations of CPNE5 were significantly lower, which was negatively correlated with the higher EC permeability, compared to the control group. Accordingly, siRNA-mediated knockdown of CPNE5 in ECs caused hyperpermeability upon stimulation with LPS or Cytomix. In vivo, we observed that loss of CPNE5 increased vascular leakage, leading to severe organ injury and higher mortality, compared to WT mice upon septic conditions. The initial mechanistic analysis showed that the reduction of CPNE5 in cardiac and pulmonary ECs was linked to the increased cleavage of membrane tight junctions and adherens junctions.
conclusionsThese observations from human sepsis patients and a murine sepsis model suggest that reduced plasma levels of CPNE5 may contribute to sepsis-induced vascular leakage and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.